FACIAL PARALYSIS

This adverse event was reported 8533 times

These drugs are most commonly taken by patients reporting FACIAL PARALYSIS:

# Drug Count
0 METHOTREXATE SODIUM 436
1 ADALIMUMAB 394
2 METHOTREXATE 381
3 ASPIRIN 359
4 PREDNISONE 359
5 ACETAMINOPHEN 352
6 ONABOTULINUMTOXINA 344
7 ASPIRIN 325 MG 341
8 ASPIRIN 81 MG 341
9 OMEPRAZOLE MAGNESIUM 313
See all common drugs associated with FACIAL PARALYSIS

FACIAL PARALYSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 SERTACONAZOLE NITRATE 6 0.0370
1 TRIHEXYPHENIDYL HYDROCHLORIDE 32 0.0314
2 CILTACABTAGENE AUTOLEUCEL 175 0.0267
3 SODIUM THIOSULFATE 10 0.0179
4 VANDETANIB 25 0.0138
5 DEOXYCHOLIC ACID 30 0.0129
6 BOTULINUM TOXIN TYPE A 125 0.0098
7 CARBAMIDE PEROXIDE 4 0.0090
8 TOFERSEN 5 0.0088
9 EFGARTIGIMOD ALFA AND HYALURONIDASE (HUMAN RECOMBINANT) 4 0.0082
See all drugs enriched for association with FACIAL PARALYSIS

FACIAL PARALYSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 32 0.0465
1 Cytolytic Agent [EPC] 30 0.0129
2 Provitamin D2 Compound [EPC] 237 0.0080
3 Protease Activator [EPC] 1 0.0078
4 CD123 Interaction [EPC] 4 0.0074
5 Guanylate Cyclase-C Agonist [EPC] 13 0.0063
6 CD38-directed Cytolytic Antibody [EPC] 36 0.0062
7 Endoglycosidase [EPC] 11 0.0059
8 Acetylcholine Release Inhibitor [EPC] 492 0.0050
9 Interleukin-17A Antagonist [EPC] 151 0.0040
See all drug classes enriched for association with FACIAL PARALYSIS